High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.

por Yeh, K. H., Cheng, A. L.
Publicado 1997

Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil

por Yeh, K-H, Yeh, S-H, Hsu, C-H, Wang, T-M, Ma, I-F, Cheng, A-L
Publicado 2000

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer

por Chao, Y, Li, C P, Chao, T Y, Su, W C, Hsieh, R K, Wu, M F, Yeh, K H, Kao, W Y, Chen, L T, Cheng, A L
Publicado 2006

Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer

por Yeh, K H, Lu, Y S, Hsu, C H, Lin, J F, Chao, H J, Huang, T C, Chung, C Y, Chang, C S, Yang, C H, Cheng, A L
Publicado 2005

Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity

por Kuo, S-H, Yeh, K-H, Chen, L-T, Lin, C-W, Hsu, P-N, Hsu, C, Wu, M-S, Tzeng, Y-S, Tsai, H-J, Wang, H-P, Cheng, A-L
Publicado 2014

Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract

por Hsu, C, Shen, Y-C, Yang, C-H, Yeh, K-H, Lu, Y-S, Hsu, C-H, Liu, H-T, Li, C-C, Chen, J-S, Wu, C-Y, Cheng, A-L
Publicado 2004

Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance

por Kuo, S-H, Chen, L-T, Lin, C-W, Wu, M-S, Hsu, P-N, Tsai, H-J, Chu, C-Y, Tzeng, Y-S, Wang, H-P, Yeh, K-H, Cheng, A-L
Publicado 2013

Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

por Chang, T. C., Shiah, H. S., Yang, C. H., Yeh, K. H., Cheng, A. L., Shen, B. N., Wang, Y. W., Yeh, C. G., Chiang, N. J., Chang, J. Y., Chen, L. T.
Publicado 2015

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer

por Chao, Y, Yeh, K H, Chang, C J, Chen, L T, Chao, T Y, Wu, M F, Chang, C S, Chang, J Y, Chung, C Y, Kao, W Y, Hsieh, R K, Cheng, A L
Publicado 2004

A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies

por Lin, C-C, Su, W-C, Yen, C-J, Hsu, C-H, Su, W-P, Yeh, K-H, Lu, Y-S, Cheng, A-L, Huang, D C-L, Fritsch, H, Voss, F, Taube, T, Yang, J C-H
Publicado 2014

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer

por Yoshino, T., Cervantes, A., Bando, H., Martinelli, E., Oki, E., Xu, R.-H., Mulansari, N.A., Govind Babu, K., Lee, M.A., Tan, C.K., Cornelio, G., Chong, D.Q., Chen, L.-T., Tanasanvimon, S., Prasongsook, N., Yeh, K.-H., Chua, C., Sacdalan, M.D., Sow (Jenson), W.J., Kim, S.T., Chacko, R.T., Syaiful, R.A., Zhang, S.Z., Curigliano, G., Mishima, S., Nakamura, Y., Ebi, H., Sunakawa, Y., Takahashi, M., Baba, E., Peters, S., Ishioka, C., Pentheroudakis, G.
Publicado 2023